ddd
NEWS
- [AsiaTechDaily] Novelty Nobility - Developing World-Class Therapeutics In Ophthalmology And Oncology
- [BioWorld] Novelty Nobility attracts $9M in series A funding for NN2101 GLP tox studies
- [한경닷컴] 박상규 노벨티노벨리티 대표 "신규 항체로 황반변성·당뇨병성 망막증 잡겠다"...
- [Mergermarket] Novelty Nobility plans up to KRW 25bn Series B in 1H21 to aid R&D efforts
- [한경닷컴] 노벨티노빌리티, 100억원 규모 투자 유치..."안질환 치료제 개발 가속화"...
6F, 227, Unjung-ro, Seongnam-si, Gyeonggi-do, S. Korea 13477
contact@noveltynobility.comCopyright ⓒ Novelty Nobility Inc.